Oramed Pharmaceuticals (ORMP) Current Taxes (2022 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Current Taxes came in at $4.6 million in Q1 2026, up 22.49% YoY from $3.8 million in Q1 2025, and up 41.21% on a QoQ basis from $3.3 million in Q4 2025.
Oramed Pharmaceuticals (ORMP) Current Taxes (2022 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 5 years of Current Taxes data on file, last reported at $4.6 million in Q1 2026.
- Quarterly Current Taxes rose 22.49% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (up 22.49% YoY) and the FY2025 annual result came in at $3.3 million, up 2.56% from the prior year.
- Current Taxes improved to $4.6 million in Q1 2026, from $3.3 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $4.6 million in Q1 2026 to a low of $11000.0 in Q4 2022.
- A 5-year average of $1.7 million and a median of $344000.0 in 2025 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2023 — Current Taxes changed 0.0% — and 2025, when it surged 34336.36%.
- Tracing ORMP's Current Taxes over 5 years: stood at $11000.0 in 2022, then changed by 0.0% to $11000.0 in 2023, then soared by 29027.27% to $3.2 million in 2024, then advanced by 2.56% to $3.3 million in 2025, then jumped by 41.21% to $4.6 million in 2026.
- The last three Current Taxes figures came in at $4.6 million (Q1 2026), $3.3 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | 6.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.27 Mn |
| Mar 31, 2026 | 4.64 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 344,000.00 |
| Mar 31, 2025 | 3.79 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 11,000.00 |